Dual antiplatelet therapy initiated up to 72 hours post-stroke cuts the risk for recurrent stroke but comes with increased bleeding risk, new data from the INSPIRES trial showed.
Groundbreaking data published in the NEJM questioned the commonly accepted 24-hour time window for administering dual antiplatelet therapy following a mild ischemic stroke.
New stroke risk down with clopidogrel-aspirin initiated within 72 hours medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.